ROBERT COHEN,SUZETTE CARR,DAVID HAGERTY,ROBERT J. PEACH,JEAN-CLAUDE BECKER
申请号：
IS6667
公开号：
IS2834B
申请日:
2003.01.02
申请国别(地区):
IS
年份:
2013
代理人:
摘要：
The present invention relates to compositions and methods for treating rheumatic disease by administering to a subject, soluble CTLA4 mutant molecules that block endogenous B7 molecules from binding their ligands.
